De Novo

FDA pathway for novel low/moderate-risk devices without a predicate.

Why it matters to buyers: Less common in imaging capital equipment; more relevant for AI/software-as-medical-device.

Why it matters to engineers: Establishes a new predicate for future 510(k)s.